Dr. Sarah Ferguson is a practicing gynecologic oncologist and member of the Princess Margaret Cancer Program with a joint position in the UHN/MSH Department of Obstetrics and Gynecology and the UHN Department of Surgical Oncology. She completed a four year fellowship at Memorial Sloan Kettering in 2006. She has made contributions to the area of molecular predictors of outcome in early stage endometrial cancer and has research interest in Lynch Syndrome-associated endometrial cancer. Her other clinical and research interests are the late effects of gynecologic cancer and its treatment on women, including sexuality and body image. She currently is the assistant medical director for the gynecologic survivorship program at the PMH Cancer Program.